In the business world, most executives are still taking a cautious approach.
As sales of appetite-suppressing drugs such as Ozempic and Mounjaro skyrocket, Corporate America is grappling with the question: How does a less-hungry, less-impulse-prone consumer affect my business model?
But by 2005, companies including General Mills Inc. were reversing course as the diet’s popularity faded amid a lack of evidence it achieves durable weight loss. Nonetheless, remnants of the Atkins Diet still linger: Chipotle Mexican Grill Inc. has burrito bowls for the carb-conscious that are now labeled as Keto and Paleo friendly. Starbucks Corp. sells high-protein boxes with cheese and eggs.
Even so, recent findings are eye-opening. A survey of GLP-1 users by Jefferies showed that more than 40% of respondents said they were eating out less. A similar percentage reported ordering less when they did. About 70% said they’re eating less overall, and roughly the same amount reported “increased awareness of nutritional benefits for foods.”
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
'Miracle weight loss' drugs Ozempic and Wegovy can cause serious side effectsThey could result in surgery.
Weiterlesen »
'Game-changing' weight-loss jabs linked to ‘severe’ stomach problems, study saysUsing weight-loss jabs such as Ozempic or Wegovy could increase the risk of 'severe gastrointestinal problems', a study has suggested.
Weiterlesen »
Study links popular weight-loss drugs to stomach paralysis, other serious gastrointestinal conditionsThey're being hailed as an effective way to lose weight, but diabetes drugs like Ozempic may come with a heightened risk of severe gastrointestinal problems.
Weiterlesen »
Weight-loss jabs increase risk of severe stomach problemsThe jabs have been found to heighten the probability of pancreatitis, bowel obstructions and “stomach paralysis”
Weiterlesen »
Weight-Loss Drugs Come With Serious Side Effects, According to a New StudyStill life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity. (Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images)
Weiterlesen »
GLP-1 weight loss drugs linked to heightened GI risks, says new studyitemprop=description content=Study from JAMA reveals that users of GLP-1 agonists, recent drugs for weight management, show a heightened risk of gastrointestinal complications like intestinal obstruction, gastroparesis, and pancreatitis. Though these effects are rare, those considering these drugs for weight loss should weigh the benefits against potential risks, especially if not using them for diabetes.
Weiterlesen »